Back
Coherus Oncology, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
CHRS
Coherus Oncology, Inc.
Last Price:
$1.64
Seasonality Move:
-3.09%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and CHRS is experiencing selling pressure, which indicates risk of future bearish movement.
Coherus Oncology, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.79 | Sell |
| 20-day SMA: | 2.04 | Sell |
| 50-day SMA: | 1.68 | Sell |
| 200-day SMA: | 1.29 | Buy |
| 8-day EMA: | 1.73 | Sell |
| 20-day EMA: | 1.5 | Buy |
| 50-day EMA: | 0.92 | Buy |
| 200-day EMA: | 0.29 | Buy |
Coherus Oncology, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 41.44 | Sell |
| Chaikin Money Flow: | -1142529 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.66 - 2.24) | Sell |
| Bollinger Bands (100): | (1.28 - 1.9) | Buy |
Coherus Oncology, Inc. Technical Analysis
| Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Coherus Oncology, Inc. Stock
Is Coherus Oncology, Inc. Stock a Buy?
-
Coherus Oncology, Inc. share price is 1.63 while CHRS 8-day simple moving average is 1.79, which is a Sell signal.
-
The stock price of CHRS is 1.63 while Coherus Oncology, Inc. 20-day SMA is 2.04, which makes it a Sell.
-
Coherus Oncology, Inc. 50-day simple moving average is 1.68 while CHRS share price is 1.63, making it a Sell technically.
-
CHRS stock price is 1.63 and Coherus Oncology, Inc. 200-day simple moving average is 1.29, creating a Buy signal.
CHRS Technical Analysis vs Fundamental Analysis
Sell
36
Coherus Oncology, Inc. (CHRS)
is a Sell
Is Coherus Oncology, Inc. a Buy or a Sell?
-
Coherus Oncology, Inc. stock is rated a SellThe current Coherus Oncology, Inc. [CHRS] share price is $1.63. The Score for CHRS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Coherus Oncology, Inc. Stock Info
Market Cap:
197M
Price in USD:
1.63
Share Volume:
1.4M
Coherus Oncology, Inc. 52-Week Range
52-Week High:
2.62
52-Week Low:
0.71
Sell
36
Coherus Oncology, Inc. (CHRS)
is a Sell
Coherus Oncology, Inc. Share Price Forecast
-
What is the Coherus Oncology, Inc. stock price today?The Coherus Oncology, Inc. stock price is 1.63 USD today.
-
Will CHRS stock go up or go down?Coherus Oncology, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Coherus Oncology, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Coherus Oncology, Inc. is overvalued.
Is Coherus Oncology, Inc. Stock a Buy?
-
Coherus Oncology, Inc. share price is 1.63 while CHRS 8-day exponential moving average is 1.73, which is a Sell signal.
-
The stock price of CHRS is 1.63 while Coherus Oncology, Inc. 20-day EMA is 1.50, which makes it a Buy.
-
Coherus Oncology, Inc. 50-day exponential moving average is 0.92 while CHRS share price is 1.63, making it a Buy technically.
-
CHRS stock price is 1.63 and Coherus Oncology, Inc. 200-day simple moving average is 0.29, creating a Buy signal.
Fundamental Analysis of Coherus Oncology, Inc.
Is Coherus Oncology, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.84 per share, and a decrease next year of $0.28 per share.
Technical Analysis of Coherus Oncology, Inc.
Should I short Coherus Oncology, Inc. stock?
-
CHRS Moving Average Covergence Divergence (MACD) indicator is 0.35, suggesting Coherus Oncology, Inc. is a Buy
-
Coherus Oncology, Inc. Relative Strength Index (RSI) is 41.44, which suggest Coherus Oncology, Inc. is oversold
-
The Bollinger Bands (25) for Coherus Oncology, Inc. is (1.66 - 2.24), which suggest Coherus Oncology, Inc. is a Buy
-
The Bollinger Bands (100) for Coherus Oncology, Inc. is (1.28 - 1.9), which suggest Coherus Oncology, Inc. is a Buy
* Coherus Oncology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.